Long-Term Outcomes From a Prospective Trial of Stereotactic Body Radiotherapy for Low-Risk Prostate Cancer

Christopher King(University of California, Los Angeles), James D. Brooks(Stanford University), Harcharan Gill(Stanford University), Joseph C. Presti(Stanford University)
International Journal of Radiation Oncology*Biology*Physics
February 7, 2011
10.1016/j.ijrobp.2010.11.054
Cited by 406

Abstract

Related Papers

Long-Term Results of the M. D. Anderson Randomized Dose-Escalation Trial for Prostate Cancer
Deborah A. Kuban, Susan L. Tucker, Lei Dong et al.|International Journal of Radiation Oncology*Biology*Physics|2007|1.2k
Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy
Stéphanie Peeters, Wilma D. Heemsbergen, P. Koper et al.|Journal of Clinical Oncology|2006|977
Randomized Trial Comparing Conventional-Dose With High-Dose Conformal Radiation Therapy in Early-Stage Adenocarcinoma of the Prostate: Long-Term Results From Proton Radiation Oncology Group/American College of Radiology 95-09
Anthony L. Zietman, Kyounghwa Bae, Jerry D. Slater et al.|Journal of Clinical Oncology|2010|743
Long-Term Outcome of High Dose Intensity Modulated Radiation Therapy for Patients With Clinically Localized Prostate Cancer
Michael J. Zeléfsky, Heather Chan, Margie Hunt et al.|The Journal of Urology|2006|465
Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: First clinical trial results
Berit Madsen, R.A. Hsi, Huong Pham et al.|International Journal of Radiation Oncology*Biology*Physics|2007|378